0 243

Cited 0 times in

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Authors
 Eugene Han  ;  Ji Hye Huh  ;  Eun Y Lee  ;  Ji C Bae  ;  Sung W Chun  ;  Sung H Yu  ;  Soo H Kwak  ;  Kyong S Park  ;  Byung-Wan Lee 
Citation
 DIABETES OBESITY & METABOLISM, Vol.24(4) : 752-756, 2022-04 
Journal Title
DIABETES OBESITY & METABOLISM
ISSN
 1462-8902 
Issue Date
2022-04
MeSH
Diabetes Mellitus, Type 2* / complications ; Diabetes Mellitus, Type 2* / drug therapy ; Dipeptidyl-Peptidase IV Inhibitors* / adverse effects ; Double-Blind Method ; Humans ; Liver ; Non-alcoholic Fatty Liver Disease* / complications ; Non-alcoholic Fatty Liver Disease* / drug therapy ; Piperazines
Keywords
dipeptidyl peptidase-4 inhibitor ; evogliptin ; magnetic resonance imaging-derived proton density fat fraction ; non-alcoholic fatty liver disease ; pioglitazone ; type 2 diabetes
Full Text
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14623
DOI
10.1111/dom.14623
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Byung Wan(이병완) ORCID logo https://orcid.org/0000-0002-9899-4992
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links